Clinical Trial Update: A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of guselkumab in Chinese participants with moderate to severe plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Psoriasis | Phase 4 | Status: COMPLETED